Neutral amino acid transport into human brain was measured using a dual-probe positron detection system or positron emission tomography (PET). Rate constants (ml/minlcc) for brain accumulation of [lIC]L methionine measured with the dual detector ranged from 0.012 to 0.078 (average 0.031) under baseline conditions and from 0.010 to 0.017 (average 0.014) after administra tion of nonradioactive L-phenylalanine (100 mg/kg). The net rate of brain accumulation of L-methionine ranged from 0.42 to 2.89 (average 1.28) nmollmin/cc, and de creased by 27.5-91.2% (average 53.9%) after L-phenylal anine. PET-estimated accumulation rates (mllmin/cc) of
Large neutral amino acids are transported from blood to brain by a saturable mechanism (Olden dorf, 1971; Yudilevich et aI. , 1972; Oldendorf and Szabo, 1976; Pardridge, 1977; Miller et aI. , 1985) . This mechanism may play a role in regulation of the rates of synthesis of brain peptides, proteins (Roberts, 1968; Oja et aI. , 1974) , and neurotrans mitters (Knott and Curzon, 1972; Wurtman and Wurtman, 1975; Wurtman et aI., 1980; Fernstrom, 1983) . Brain transport of amino acids has been ex amined extensively in experimental animals, and human studies have become possible because of the increasing availability of positron-emitting tracers (Bustany et aI. , 1981; Comar et aI. , 1981; Leenders et aI., 1986; Bergstrom et aI. , 1987) . We have quan-after L-phenylalanine. Initial volumes of distribution (mIl cc) of [lIC]L-methionine (dual detector) were 0.044-0.070 (average 0.058) baseline and 0.032-0.074 (average 0.051) after phenylalanine and (PET) 0.026-0.098 (average 0.051) baseline and 0.021-0.061 (average 0.042) after phenylalanine. PET permits more accurate measurement of tracer accumulation by brain, excluding noncerebral regions included in dual-detector measurements. The dual-detector system permits better temporal resolution, facilitating kinetic analysis, and requires only one-for tieth the dose of tracer needed for PET. Multiple studies in the same patient are thus possible at low cost. Key Words: Amino acid transport-Human brain tumor-L Methionine.
tified L-methionine transport into brain using one of two techniques involving positron-emitting nu clides. In the first method we detected radiotracer accumulation by brain as reflected in the field of view of a dual-detector system. In the second method, we assessed accumulation of tracer in normal brain regions using reconstructed positron emission tomography (PET) images. Data for the dual-detector studies were obtained in normal vol unteers; the PET images were studied in patients with brain tumor.
MATERIALS AND METHODS
The dual-probe positron detection system consists of a pair of ')I-photon detectors designed to measure positron annihilation radiation (Bice et aI., 1986) . By the coinci dent detection of annihilation ')I-rays, tracer radioactivity can be measured in regions of the brain viewed by the detectors. The shape and magnitude of the time-radioac tivity curve reflect the kinetics of the positron-emitting radio tracer. Using the dual-detector system, we mea sured [lIC]L-methionine accumulation in brain of normal volunteers, before and after administration of L-phenylal anine to block L-methionine uptake.
Informed consent was obtained from each of the four subjects, who abstained from food for 8-9 h prior to the study. The hand opposite the site of injection of the tracer was warmed by means of a heating pad to permit sam pling of "arterialized" venous blood. A face mask, fabri cated from a synthetic lightweight plastic "polyform," was used to aid in positioning and to inhibit subject mo tion. The subject lay on a stretcher, with the head cen tered between the detectors, which were directed over the midtemporal regions. Prior to the injection of [IIClL methionine, blood was sampled (I-ml aliquots) for esti mation of neutral amino acids.
[IIClL-Methionine (360-410 fLCi) was injected intrave nously and [IIClL-methionine accumulation in the de tector's field of view was recorded for 40-60 min after injection of the tracer. Blood samples (0.5 or 1 ml) were obtained from the contralateral dorsal hand vein.
Because IIC radioactivity decays with a 20-min half life, a second study could be performed 3 h later. One hour prior to the second study, the subject received an oral dose of 100 mg/kg of L-phenylalanine, and a further blood sample was obtained for amino acid analysis. The timing of the blood sampling was based on clinical data concerning blood phenylalanine response to oral loads (Knox, 1983) . Subsequent procedures were the same as in the first study.
Blood IIC radioactivity was measured in units of counts per second per sample volume and subsequently converted to microcuries per cubic centimeter. This con version was based on calibration experiments using a source of known radioactivity counted in the same well counter. Radioactivity measured in the field of view of the detectors was corrected for detector sensitivity using a brain phantom containing a known concentration of ac tivity.
Results obtained with the dual-detector system in normal persons were compared with those obtained by PET imaging in seven patients with brain tumor, using a Neuro-ECAT II system (C.T.I., Knoxville, TN, U.S.A.) with in-plane axial resolution of 8mm. These patients re ceived 18-21 mCi [IIClL-methionine i.v., followed in three cases by a second study after ingestion of L-phenyl alanine. Imaging began 30 s after tracer injection. The acquired tomographic planes were oriented parallel to the inferior orbitomeatal line. Each plane set comprised three tomographic slices separated by 32 mm. Three plane sets were obtained sequentially with a I-min acquisition time and 1 min between sets. Acquisition of the first plane set was complete by 6 min. A second group of three plane sets in the same orientation was then obtained, with 2-min acquisition time per slice. This phase of the study terminated -16 min after tracer injection. Subsequently (in most cases) a final set of planes was acquired in the original position. This acquisition was of 5-min duration and started 20-24 min after injection. All PET data were assigned to a time at the midpoint of the acquisition in terval.
On the reconstructed images, regions of interest were placed over normal areas of the cerebral cortex. Time-ac tivity curves for radiomethionine accumulation were gen erated from these regions, which comprised 15-20 pixels of 0.64-cm2 area per pixel. Tr acer concentration in micro curies per cubic centimeter brain was calculated by using a known source concentration in a head phantom as for the dual-detector studies. Correction for attenuation was carried out during the reconstruction process. Blood J Cereb Blood Flow Metah, Vol. 8, No.3, 1988 [IIClL-methionine time-activity curves were determined as for the dual-detector studies.
RESULTS
Baseline values of all neutral amino acids were within normal limits. After phenylalanine adminis tration, blood phenylalanine levels showed a 2.56to 11.9-fold increase over baseline values. The ratio of phenylalanine to other neutral amino acids showed a similar trend (2.0-to 15.9-fold increase). Neutral amino acids other than phenylalanine re mained within normal limits after phenylalanine ad ministration.
Blood clearance of [lIC]L-methionine was similar both in baseline and in postphenylalanine studies (Fig. 1). [1IC]L-Methionine brain time-activity curves for all studies, both dual detector and PET, was characterized by a rapid initial accumulation for 5-10 min, after which the activity level pla teaued.
Blood and brain time-activity curves were ana lyzed by a mathematical model of blood-brain solute exchange (the "integral plot" technique) (Gjedde, 1982; Patlak et aI. , 1983) , This model allows assessment of the unidirectional transfer process during the study period. The operational equation is
where Am is the total amount of [IIC]L-methionine in the tissue, Kj is the rate constant for tracer transfer from blood to brain, Cp is the tracer con centration in blood at time t, and Vp is the initial volume of distribution of the tracer. This equation describes a linear function if the normalized tissue radioactivity (Am/Cp) is plotted against the "effec tive time" (f6CpdtICp(t ». The slope of this plot is Kj and the intercept is Vp.
The ordinate of this plot has units of milliliters of radiolabel per cubic centimeter of tissue. The ab scissa has units of time and represents the equiva lent time if the blood concentration is held con stant. The slope of this plot is the rate of transport of [IIC]L-methionine into the brain, expressed as a clearance constant with the units of milliliters per minute per cubic centimeter (Fig. 2) .
The initial straight line (Fig. 3 ) was defined as that providing the best least-squares fit to the early data. This was obtained from the earliest effective time that the normalized brain activity was greater than background until it deviated from a linear in- nylalanine, all subjects showed a decrease in [lIC]L-methionine accumulation, averaging 33% and ranging from 14 to 78%. After blockade, the initial volume of distribution ranged from 0.032 to 0.074 (average 0.050) mllcc. Accumulation rates calculated from the PET studies (Table 2) ranged from 0.004 to 0.028 (average 0.016) mllmin/cc in the baseline studies. After administration of phenylala nine, the rates decreased by 19 and 64% in two pa tients and increased by 133% in a third patient. The initial volume of distribution ranged from 0.026 to 0.098 ml/cc under baseline conditions and from 0.021 to 0.061 mllcc after phenylalanine. By combining the measured blood methionine levels and the dual-detector-estimated radioactivity transfer rates, the net accumulation rate of L-methi onine was calculated in units of nanomoles per minute per cubic centimeter (Table 3) . Values 
DISCUSSION
The initial slope of the integral-time plot reflects the rate of transport across the blood -brain barrier. Therefore, the observed changes in slope are attrib utable to saturation of L-methionine transport by L phenylalanine. The magnitude of the decrease in accumulation of [11C]L-methionine by normal brain in the four volunteers studied by the dual detector is similar to that described by Comar et al. (1981) , who found that phenylalanine administration pro duced a 50% reduction in methionine accumulation by the brain. Two of the three patients examined by PET likewise showed a reduction in methionine ac cumulation, whereas one showed an increase. Our values for the transfer rate of L-methionine into the brain of normal persons are similar to those ob tained in another PET study (Bergstrom et al. , 1987). We noted substantial variation in the accu mulation rates of [llC]L-methionine by brain, both for the dual-detector and the PET studies. Similar variation is noted in other studies of amino acid transport, both in animals (Banos et al. , 1973) and in isolated human capillaries (Choi and Pardridge, 1986) . The initial rate of ["C]L-methionine uptake is not significantly affected by the presence of me tabolites; use of data obtained later (e. g., Berg strom et al. , 1987) requires correction for metabo lites.
The values obtained with the dual-detector system were higher than those obtained with the PET study. This difference may be attributable in part to the inclusion in the field of view of tissues other than brain, such as muscle, which also ac tively accumulate neutral amino acids (Kostyo and Schmidt, 19863; James et al. , 1985) . Thus, the rates determined with the dual detector represent an average of all the tissues within the field of view of the probes. Preliminary analysis of the PET scans indicates that this volume is composed of -85% brain tissue. To investigate this difference further, we plan to perform both PET and dual-detector studies in the same subject.
PET imaging allows definition of discrete regions of interest over selected anatomic areas. Hence, PET imaging must be used when regional uptake rates are required, e.g. , for a tumor. However, the time needed to acquire enough counts to perform the reconstruction plus the time required to reset the scanner between acquisitions limit the temporal resolution of the method and hence its ability to trace dynamic events. Conversely, the dual-de tector system has much lower spatial resolution but has higher temporal resolution. This feature permits a more accurate kinetic analysis especially of the early stages of tracer accumulation by the tissues, when the tissue concentration is changing rapidly. For example, as many as nine data points contributed to the slopes determined by the dual detector, whereas only three were used for the PET data. Another advantage of the dual-detector system is that a much lower dose of tracer is re quired. This permits monitoring of the effects of perturbations over extended periods without exces sively high radiation exposure to the subject.
